Skip to main content
Back
Watch Compare

Jasper Therapeutics, Inc.

Data quality: 83%
Also listed as JSPRW Nasdaq
JSPR
Nasdaq Manufacturing Chemicals
$0.82
▲ $0.12 (16.48%)
Mkt Cap: 23.06 M
Price
$0.82
Mkt Cap
23.06 M
Day Range
$0.71 — $0.85
52-Week Range
$0.62 — $7.19
Volume
1,139,874
Open $0.72
50D / 200D Avg
$1.27
35.37% below
50D / 200D Avg
$2.26
63.62% below

Quick Summary

Key Takeaways

Negative free cash flow of -77.16 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-432.26%
Below sector avg (-53.41%)
ROIC-212.42%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio2.59
Interest CoverageN/A

Valuation

PE (TTM)
-0.30
Above sector avg (-1.48)
P/B Ratio1.99
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.3 -1.5
P/B 2.0 1.6
ROE % -432.3 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

SURI logo SURI Simplify Propel Opportunities ETF
2.10% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -75.80 M
ROE -432.26% ROA -145.86%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -77.16 M
ROIC -212.42% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.59
Interest Coverage N/A Asset Turnover N/A
Working Capital 33.52 M Tangible Book Value 11.57 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.30 Forward P/E N/A
P/B Ratio 1.99 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -334.64%
Market Cap 23.06 M Enterprise Value -27.84 M
Per Share
EPS (Diluted TTM) -3.95 Revenue / Share N/A
FCF / Share -2.76 OCF / Share -2.76
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 101.79%
SBC-Adj. FCF -84.21 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -75.80 M -71.27 M -64.47 M -37.69 M -30.64 M
EPS (Diluted) -3.95 -4.89 -6.18 -1.03 —
Gross Profit — — — — —
Operating Income -83.88 M -76.24 M -68.86 M -51.20 M -36.83 M
EBITDA — — — — —
R&D Expenses 63.10 M 55.82 M 51.79 M 34.63 M 25.42 M
SG&A Expenses — — — — —
D&A 1.06 M 1.37 M 1.11 M 975,000.0 377,000.0
Interest Expense — — -246,000.0 — -80,000.0
Income Tax 2,000.0 2,000.0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 35.78 M 79.90 M 94.89 M 48.36 M 93.65 M
Total Liabilities 31.63 M 18.23 M 16.45 M 12.37 M 24.14 M
Shareholders' Equity 4.15 M 61.67 M 78.44 M 35.99 M 69.52 M
Total Debt — — — — —
Cash & Equivalents 28.69 M 71.64 M 86.89 M 38.25 M 84.70 M
Current Assets 34.65 M 75.81 M 88.94 M 41.73 M 87.83 M
Current Liabilities 13.20 M 15.24 M 12.37 M 7.07 M 8.02 M